The National Multiple Sclerosis Society stresses that with over 2.1 million people worldwide living with multiple sclerosis (MS), demonstrating the power and importance of the...
Hologic, Inc. recently announced that its 3D mammography technology showed a significant reduction in recall rates and a sizeable increase in cancer detection, particularly invasive...
Oncolytics Biotech Inc. recently announced preliminary results from a mid-stage trial for its metastatic melanoma drug. The Phase 2 clinical trial, evaluating the use of...
TAMPA, Fla. , May 23, 2013 —The National Association of Specialty Pharmacy™ (NASP™) announced today that Diane E. Sullivan, Vice President, Specialty Payer & Channel...
US spending on specialty prescription drugs is projected to increase 67 percent by the end of 2015, according to a forecast released by Express Scripts....